{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T22:51:40Z","timestamp":1768431100928,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00702-020-02209-8","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T10:02:57Z","timestamp":1590660177000},"page":"1107-1115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dependence liability of lormetazepam: are all benzodiazepines equal? The case of the new i.v. lormetazepam for anesthetic procedures"],"prefix":"10.1007","volume":"127","author":[{"given":"Reinhard","family":"Horowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"2209_CR1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hup.572","volume":"19","author":"C Ancolio","year":"2004","unstructured":"Ancolio C, Tardieu S, Soubrouillard AC, Pradel V, Micallef J, Blin O (2004) A randomized clinical trial comparing doses and efficacy of lormetazepam tablets or oral solution for insomnia in a general practice setting. Hum Psychopharmacol 19:129\u2013134","journal-title":"Hum Psychopharmacol"},{"key":"2209_CR2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5694\/j.1326-5377.2004.tb06293.x","volume":"181","author":"CL Breen","year":"2004","unstructured":"Breen CL, Degenhardt LJ, Bruno RB, Roxburgh AD, Jenkinson R (2004) The effects of restricting publicly subsidized temazepam capsules on benzodiazepine use among injecting drug users in Australia. Med J Aust 181:300\u2013304","journal-title":"Med J Aust"},{"key":"2209_CR3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.comppsych.2016.06.008","volume":"69","author":"F Cosci","year":"2016","unstructured":"Cosci F, Mansueto G, Faccini M, Casari R, Lugoboni F (2016) Socio-demographic and clinical characteristics of benzodiazepine long-term users: results from a tertiary care center. Compr Psychiatry 69:211\u2013215","journal-title":"Compr Psychiatry"},{"key":"2209_CR4","first-page":"14","volume":"11","author":"RJ Dinis-Oliveira","year":"2017","unstructured":"Dinis-Oliveira RJ (2017) Metabolic profile of flunitrazepam: clinical and forensic toxicological aspects. Drug Metab Lett 11:14\u201320","journal-title":"Drug Metab Lett"},{"key":"2209_CR5","first-page":"561","volume":"13","author":"R Dorow","year":"1982","unstructured":"Dorow R, Seidler J, Schneider HH (1982) A radioreceptor assay to study the affinity of benzodiazepines and their receptor binding activity in human plasma including their active metabolite. Br J Pharmacol 13:561\u2013565","journal-title":"Br J Pharmacol"},{"key":"2209_CR6","doi-asserted-by":"crossref","unstructured":"Dorow R (1987) Pharmacokinetic and clinical studies with a benzodiazepine radioreceptor assay. Psychopharmacology Suppl 1:105\u2013118 (review)","DOI":"10.1007\/978-3-642-69659-6_10"},{"key":"2209_CR7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.drugpo.2007.09.004","volume":"19","author":"R Dwyer","year":"2008","unstructured":"Dwyer R (2008) Privileging pleasure: temazepam injection in a heroin marketplace. Int J Drug Policy 19:367\u2013374","journal-title":"Int J Drug Policy"},{"key":"2209_CR8","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11739-019-02101-8","volume":"14","author":"M Faccini","year":"2019","unstructured":"Faccini M, Tamburin S, Casari R, Morbioli L, Lugoboni F (2019) High dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde. Intern Emerg Med 14:1271\u20131278","journal-title":"Intern Emerg Med"},{"key":"2209_CR9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00498258009033775","volume":"10","author":"R Girkin","year":"1980","unstructured":"Girkin R, Baldock GA, Chasseaud LF, H\u00fcmpel M, Hawkins DR, Mayo BC (1980) The absorption, distribution and excretion of [14C] lormetazepam in dogs, rabbits, rats and rhesus monkeys. Xenobiotica 10:401\u2013411","journal-title":"Xenobiotica"},{"key":"2209_CR10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0009-9236(98)90057-1","volume":"64","author":"DJ Greenblatt","year":"1998","unstructured":"Greenblatt DJ, von Moltke LL, Harmatz JS, Mertzanis P, Graf JA, Durol AL, Counihan M, Roth-Schechter B, Shader RI (1998) Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole. Clin Pharmacol Ther 64:661\u2013671","journal-title":"Clin Pharmacol Ther"},{"key":"2209_CR11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1517\/17425255.2012.741588","volume":"8","author":"DJ Greenblatt","year":"2012","unstructured":"Greenblatt DJ, Zammit GK (2012) Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications. Expert Opin Drug Metab Toxicol 8:1609\u20131618","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2209_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","volume":"9","author":"N Gunja","year":"2013","unstructured":"Gunja N (2013) The clinical and forensic toxicology of Z-drugs. J Med Toxicol 9:155\u2013162","journal-title":"J Med Toxicol"},{"key":"2209_CR13","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/add.12094","volume":"108","author":"K Hayashi","year":"2013","unstructured":"Hayashi K, Suwannawong P, Ti L, Kaplan K, Wood E, Kerr T (2013) High rate of midazolam injection and associated harms in Bangkok, Thailand. Addiction 108:944\u2013952","journal-title":"Addiction"},{"key":"2209_CR14","first-page":"1","volume":"67","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M (2018) Drugs most frequently involved in drug overdose deaths: United States, 2011\u20132016. Natl Vital Stat Rep 67:1\u201314","journal-title":"Natl Vital Stat Rep"},{"key":"2209_CR15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.bja.2018.12.025","volume":"122","author":"S Hemphill","year":"2019","unstructured":"Hemphill S, McMenamin L, Bellamy MC, Hopkins PM (2019) Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth 122:448\u2013459","journal-title":"Br J Anaesth"},{"key":"2209_CR16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03190123","volume":"15","author":"M Hildebrandt","year":"1990","unstructured":"Hildebrandt M, Hellstern A, H\u00fcmpel M, Hellenbrecht D, Saller R (1990) Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers. Eur J Drug Metab Pharmacokinet 15:19\u201326","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2209_CR17","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00115-014-4016-8","volume":"85","author":"F Hoffmann","year":"2014","unstructured":"Hoffmann F, Glaeske G (2014) Benzodiazepine hypnotics, zolpidem and zopiclone on private prescriptions: use between 1993 and 2012 (in German). Nervenarzt 85:1402\u20131409","journal-title":"Nervenarzt"},{"key":"2209_CR18","unstructured":"Hoernecke R (2011) US patent US20110263576A1"},{"key":"2209_CR19","first-page":"632","volume":"23","author":"R Horowski","year":"1982","unstructured":"Horowski R, Dorow R (1982) Significance of pharmacokinetic findings for the clinical effect of benzodiazepines. Internist (Berl) 23:632\u2013640","journal-title":"Internist (Berl)"},{"key":"2209_CR20","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00702-019-02136-3","volume":"127","author":"R Horowski","year":"2020","unstructured":"Horowski R (2020) FG7142: is this validated tool to study anxiety now forgotten? J Neural Transm 127:287\u2013289","journal-title":"J Neural Transm"},{"key":"2209_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF03189433","volume":"4","author":"M H\u00fcmpel","year":"1979","unstructured":"H\u00fcmpel M, Illi V, Milius W, Wendt H, Kurowski M (1979) The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C. Eur J Drug Metab Pharmacokinet 4:237\u2013243","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2209_CR22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/clpt.1980.220","volume":"28","author":"M H\u00fcmpel","year":"1980","unstructured":"H\u00fcmpel M, Nieuweboer B, Milius W, Hanke H, Wendt H (1980) Kinetics and biotransformation of lormetazepam. II. Radioimmunologic determinations in plasma and urine of young and elderly subjects: first-pass effect. Clin Pharmacol Ther 28:673\u2013679","journal-title":"Clin Pharmacol Ther"},{"key":"2209_CR23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00542330","volume":"21","author":"M H\u00fcmpel","year":"1982","unstructured":"H\u00fcmpel M, Stoppelli I, Milia S, Rainer E (1982) Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. Eur J Clin Pharmacol 21:421\u2013425","journal-title":"Eur J Clin Pharmacol"},{"key":"2209_CR24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.forsciint.2016.08.015","volume":"267","author":"AW Jones","year":"2016","unstructured":"Jones AW, Holmgren A, Ahlner J (2016) Post-mortem concentrations of drugs determined in femoral blood in single-drug fatalities compared with multi-drug poisoning deaths. Forensic Sci Int 267:96\u2013103","journal-title":"Forensic Sci Int"},{"key":"2209_CR25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/clpt.1981.130","volume":"30","author":"D Kampf","year":"1981","unstructured":"Kampf D, H\u00fcmpel M, Lurche U, Kessel M (1981) The effects of uremia and hemodialysis on lormetazepam disposition. Clin Pharmacol Ther 30:77\u201385","journal-title":"Clin Pharmacol Ther"},{"key":"2209_CR26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1055\/s-2008-1070941","volume":"105","author":"N Kemper","year":"1980","unstructured":"Kemper N, Poser W, Poser S (1980) Benzodiazepine dependence: addiction potential of the benzodiazepines is greater than previously assumed. Dtsch Med Wochenschr 105:1707\u20131712","journal-title":"Dtsch Med Wochenschr"},{"key":"2209_CR27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2125.1985.tb02619.x","volume":"19","author":"U Klotz","year":"1985","unstructured":"Klotz U, Duka T, Dorow R, Doenicke A (1985) Flunitrazepam and lormetazepam do not affect the pharmacokinetics of the benzodiazepine antagonist Ro 15\u20131788. Br J Clin Pharmacol 19:95\u201398","journal-title":"Br J Clin Pharmacol"},{"key":"2209_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2007-1019513","volume":"15","author":"M Kurowski","year":"1982","unstructured":"Kurowski M, Ott H, Herrmann WM (1982) Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam. Pharmacopsychiatria 15:77\u201383","journal-title":"Pharmacopsychiatria"},{"key":"2209_CR29","doi-asserted-by":"crossref","unstructured":"Luetz A, Weiss B, Spies CD (2014) Intravenous lormetazepam during sedation weaning in a 26-year-old critically ill woman. Case Rep Crit Care 2014 art. ID 372740","DOI":"10.1155\/2014\/372740"},{"key":"2209_CR30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/14740338.2019.1628216","volume":"18","author":"F Lugoboni","year":"2019","unstructured":"Lugoboni F, Mirijello A, Morbioli L, Faccini M, Casari R, De Cosmo S, Gasbarrini A, Addolorato G (2019) Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients. Expert Opin Drug Saf 18:753\u2013758","journal-title":"Expert Opin Drug Saf"},{"key":"2209_CR31","first-page":"99","volume":"1","author":"DK Luscombe","year":"1984","unstructured":"Luscombe DK (1984) Lormetazepam\u2013plasma concentrations in volunteers following sublingual and oral dosing. Psychopharmacology 1:99\u2013104","journal-title":"Psychopharmacology"},{"key":"2209_CR32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00101-016-0260-6","volume":"66","author":"C Maier","year":"2017","unstructured":"Maier C, Iwunna J, Tsokos M, Mu\u00dfhoff F (2017) Deaths from propofol abuse: survey of institutes of forensic medicine in Germany, Austria and Switzerland. Anaesthesist 66:109\u2013114","journal-title":"Anaesthesist"},{"key":"2209_CR33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","volume":"565","author":"S Masiulis","year":"2019","unstructured":"Masiulis S, Desai R, Ucha\u0144ski T, Serna Martin I, Laverty D, Karia D, Malinauskas T, Zivanov J, Pardon E, Kotecha A, Steyaert J, Miller KW, Aricescu AR (2019) GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature 565:454\u2013459","journal-title":"Nature"},{"key":"2209_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0376-8716(98)00110-0","volume":"53","author":"MZ Mintzer","year":"1998","unstructured":"Mintzer MZ, Griffiths RR (1998) Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability. Drug Alcohol Depend 53:49\u201366","journal-title":"Drug Alcohol Depend"},{"key":"2209_CR35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/01.fbp.0000172736.11994.3c","volume":"16","author":"MZ Mintzer","year":"2005","unstructured":"Mintzer MZ, Griffiths RR (2005) An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers. Behav Pharmacol 16:579\u2013584","journal-title":"Behav Pharmacol"},{"key":"2209_CR36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0022-3565(25)24438-X","volume":"272","author":"GK Mumford","year":"1995","unstructured":"Mumford GK, Rush CR, Griffiths RR (1995) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570\u2013580","journal-title":"J Pharmacol Exp Ther"},{"key":"2209_CR37","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/bmj.284.6319.860","volume":"284","author":"I Oswald","year":"1982","unstructured":"Oswald I, French C, Adam K, Gilham J (1982) Benzodiazepine hypnotics remain effective for 24 weeks. Br Med J (Clin Res Ed) 284:860\u2013863","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2209_CR38","unstructured":"Poser W, Poser S (1996) Medikamente\u2014Missbrauch und Abh\u00e4ngigkeit (in German). Thieme Stuttgart\/New York"},{"key":"2209_CR39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2007.02.006","volume":"564","author":"RB Raffa","year":"2007","unstructured":"Raffa RB, Cavallo F, Capasso A (2007) Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. Eur J Pharmacol 564:88\u201393","journal-title":"Eur J Pharmacol"},{"issue":"464","key":"2209_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.scitotenv.2013.05.045","volume":"463","author":"C Repice","year":"2013","unstructured":"Repice C, Dal Grande M, Maggi R, Pedrazzani R (2013) Licit and illicit drugs in a wastewater treatment plant in Verona. Italy Sci Total Environ 463(464):27\u201334","journal-title":"Italy Sci Total Environ"},{"key":"2209_CR41","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","volume":"22","author":"F Schiffano","year":"2019","unstructured":"Schiffano F, Chiappini S, Corkery JM, Guirguis A (2019) An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency database of suspected adverse drug reactions. Int J Neuropsychopharmacol 22:270\u2013277","journal-title":"Int J Neuropsychopharmacol"},{"key":"2209_CR42","volume-title":"Arzneiverordnungsreport (in German)","year":"2016","unstructured":"Schwabe U, Paffrath D (eds) (2016) Arzneiverordnungsreport (in German). Springer, Berlin"},{"key":"2209_CR43","first-page":"20","volume":"21","author":"H Suttmann","year":"1990","unstructured":"Suttmann H, Rampf U, Juhl G, Greim M, Doenicke A (1990) Beta-Aktivierung nach intraven\u00f6ser Gabe von Benzodiazepinen und dem spezifischen Antagonisten Flumazenil (in German). Z EEG-EMG 21:20\u201328","journal-title":"Z EEG-EMG"},{"key":"2209_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jclinane.2008.12.030","volume":"22","author":"J Tetzlaff","year":"2010","unstructured":"Tetzlaff J, Collins GB, Brown DL, Leak BC, Pollock G, Popa D (2010) A strategy to prevent substance abuse in an academic anesthesiology department. J Clin Anesth 22:143\u2013150","journal-title":"J Clin Anesth"},{"key":"2209_CR45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s002130050487","volume":"135","author":"EM Weerts","year":"1998","unstructured":"Weerts EM, Kaminski BJ, Griffiths RR (1998) Stable low-rate midazolam self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Psychopharmacology 135:70\u201381","journal-title":"Psychopharmacology"},{"key":"2209_CR46","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.2013.281954","volume":"310","author":"DO Warner","year":"2013","unstructured":"Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR (2013) Substance use disorder among anesthesiology residents, 1975\u20132009. JAMA 310:2289\u20132296","journal-title":"JAMA"},{"key":"2209_CR47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1399-6576.1995.tb04374.x","volume":"108","author":"JG Whitwam","year":"1995","unstructured":"Whitwam JG, Amrein R (1995) Amrein R (1995) Pharmacology of flumazenil. Acta Anaesthesiol Scand Suppl 108:3\u201314","journal-title":"Acta Anaesthesiol Scand Suppl"},{"key":"2209_CR48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0376-8716(91)90044-Y","volume":"29","author":"B Wolf","year":"1991","unstructured":"Wolf B, Griffiths RR (1991) Physical dependence on benzodiazepines: differences within the class. Drug Alcohol Depend 29:153\u2013156","journal-title":"Drug Alcohol Depend"},{"key":"2209_CR49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0031-6997(25)06658-X","volume":"39","author":"JH Woods","year":"1987","unstructured":"Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39:251\u2013413","journal-title":"Pharmacol Rev"},{"key":"2209_CR50","first-page":"251","volume":"11","author":"T Yanagita","year":"1985","unstructured":"Yanagita T, Kato S, Mikami M (1985) Dependence potential of lormetazepam studied in rhesus monkeys. Preclin Rep Cent Inst Exp 11:251\u2013413","journal-title":"Preclin Rep Cent Inst Exp"},{"key":"2209_CR51","first-page":"1870","volume":"35","author":"L Zecca","year":"1985","unstructured":"Zecca L, Reina L, Scaglione F, Ferrario P, Pirola R, Ceccarelli G, Ciampini M, Fraschini F (1985) Relative bioavailability in humans for oral tablets and solutions of lormetazepam. Arzneimittelforschung 35:1870\u20131872","journal-title":"Arzneimittelforschung"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02209-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00702-020-02209-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-020-02209-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:44:15Z","timestamp":1744166655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00702-020-02209-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2209"],"URL":"https:\/\/doi.org\/10.1007\/s00702-020-02209-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"9 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author had been paid by former Schering AG where as an employee until 1999, he also was in charge of lormetazepam. He fully owns Antaxios GmbH, a start-up company specialized in medical expert opinions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}